These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Levodopa in pregnancy. Nomoto M; Kaseda S; Iwata S; Osame M; Fukuda T Mov Disord; 1997 Mar; 12(2):261. PubMed ID: 9087994 [No Abstract] [Full Text] [Related]
3. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa. Med Lett Drugs Ther; 2005 Jan; 47(1201):12. PubMed ID: 15706700 [TBL] [Abstract][Full Text] [Related]
4. What to do when Sinemet fails: Part one. Klawans HL Clin Neuropharmacol; 1984; 7(2):121-33. PubMed ID: 6733692 [No Abstract] [Full Text] [Related]
5. First emergence of "delayed-on" and "dose failure" phenomena in a patient with Parkinson's disease following vagotomy. Djaldetti R; Achiron A; Ziv I; Melamed E Mov Disord; 1994 Sep; 9(5):582-3. PubMed ID: 7990855 [No Abstract] [Full Text] [Related]
6. Medical treatment of Parkinson's disease. Ahlskog JE Compr Ther; 1989 Mar; 15(3):53-9. PubMed ID: 2650977 [No Abstract] [Full Text] [Related]
7. Guillain-Barre/CIDP-like neuropathy in two parkinsonian patients following intestinal levodopa/carbidopa treatment. Galazky I; Schoof J; Stallforth S; Kupsch A; Heinze HJ; Kluge C Parkinsonism Relat Disord; 2014 Jan; 20(1):125-7. PubMed ID: 24044946 [No Abstract] [Full Text] [Related]
9. Duopa--a carbidopa/levodopa enteral suspension for Parkinson's disease. Med Lett Drugs Ther; 2015 Aug; 57(1474):112. PubMed ID: 26218794 [No Abstract] [Full Text] [Related]
10. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222 [TBL] [Abstract][Full Text] [Related]
11. Square-wave action dystonia in Parkinson's disease. van den Munckhof P; Lenz FA; Chase TN Mov Disord; 1998 Mar; 13(2):354-6. PubMed ID: 9539355 [No Abstract] [Full Text] [Related]
12. Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study Group. Wolters EC; Horstink MW; Roos RA; Jansen EN Adv Neurol; 1993; 60():648-52. PubMed ID: 8420204 [No Abstract] [Full Text] [Related]
13. High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias. Facca A; Sanchez-Ramos J Mov Disord; 1996 May; 11(3):327-9. PubMed ID: 8723153 [No Abstract] [Full Text] [Related]
14. Necessity of long-term alertness in levodopa-carbidopa intestinal gel infusion for PD patients. Klostermann F; Bojarski C; Marzinzik F; Maier A; Schindlbeck KA; Ehlen F Mov Disord; 2017 Feb; 32(2):300-301. PubMed ID: 27859611 [No Abstract] [Full Text] [Related]
15. Clinical experience with the novel levodopa formulation entacapone + levodopa + carbidopa (Stalevo). Silver DE Expert Rev Neurother; 2004 Jul; 4(4):589-99. PubMed ID: 15853578 [TBL] [Abstract][Full Text] [Related]